Buccal Mucosa Cancer: Symptoms, Stages, Surgery & Recovery

A persistent, painless ulcer on the inside of the cheek is one of the most overlooked warning signs of oral cancer. Patients frequently dismiss it as a canker sore, a cheek bite, or irritation from a sharp tooth. But when an ulcer or patch on the inner cheek lining (the buccal mucosa) fails to heal within two to three weeks, it demands urgent specialist evaluation.

Buccal mucosa cancer is among the most common oral malignancies encountered in India, driven largely by the widespread use of smokeless tobacco, gutka, and betel quid. In our practice at Mouth Cancer Surgeons in Chennai, we see a disproportionate number of patients who have ignored early warning signs, allowing the disease to advance to stages that require far more extensive surgery.

This guide covers buccal mucosa cancer from the earliest symptoms and the role of gutka and paan masala in causing mouth cancer, through biopsy, staging, surgery, reconstruction, and recovery.

---

What Is the Buccal Mucosa and Why Is It Vulnerable to Cancer?

The buccal mucosa is the moist, pink tissue that lines the inner surface of the cheeks and lips. Anatomically, it extends from the junction where the cheek lining meets the gums (the mucosal attachment to the alveolar ridge) back to the pterygomandibular raphe, the fold of tissue at the rear of the cheek near the last molar teeth.

Buccal mucosa cancer is a subtype of oral cavity cancer, and the overwhelming majority of cases are diagnosed as Oral Squamous Cell Carcinoma (OSCC). Squamous cells are the flat, scale-like cells that form the surface layer of the oral mucosa. When chronic exposure to carcinogens causes these cells to accumulate genetic mutations, they begin dividing uncontrollably, forming a tumour that eventually invades the deeper buccinator muscle, adjacent jawbones, and regional lymph nodes in the neck.

Why India Has One of the Highest Rates Globally

India and South Asia have a far higher incidence of buccal mucosa cancer than Western countries, and the difference is explained almost entirely by smokeless tobacco habits. Products such as gutka, khaini, paan masala, zarda, and betel quid (paan) with areca nut are placed in the buccal sulcus (the pocket between the cheek and the teeth) and held there for prolonged periods, sometimes for hours at a stretch.

The cheek lining is exposed to a concentrated dose of carcinogens for hours every day. The carcinogenic nitrosamines in tobacco, combined with the genotoxic alkaloids in areca nut (primarily arecoline), cause progressive cellular damage through three overlapping mechanisms:

1. Chronic Inflammation: The continuous irritation triggers a persistent inflammatory response in the mucosal cells.

2. Submucosal Fibrosis: Repeated exposure causes the connective tissue beneath the mucosa to become thick and fibrous, a condition known as Oral Submucous Fibrosis (OSMF). OSMF is itself an oral potentially malignant disorder with a well-documented rate of malignant transformation.

3. DNA Damage: Carcinogenic metabolites directly damage the DNA of the squamous cells, causing mutations in tumour-suppressor genes (such as TP53) that ultimately lead to uncontrolled cell growth.

If you currently use any form of smokeless tobacco, read our guide on quitting tobacco after an oral precancer diagnosis.

---

Recognising the Early Symptoms of Buccal Mucosa Cancer

Stage at diagnosis is the strongest predictor of survival. Because early buccal mucosa cancer is often painless, it has to be looked for.

Early Warning Signs

• The Non-Healing Ulcer: A sore on the inner cheek that persists for more than 14 days. Unlike a common canker sore, a malignant ulcer typically has raised, hardened (indurated) borders, bleeds easily when touched, and does not respond to topical ointments. Learn how to tell the difference in our guide on warning signs of a malignant mouth ulcer.

• White or Red Patches: Persistent white patches (leukoplakia) or velvety red patches (erythroplakia) on the inner cheek. These are classified as oral potentially malignant disorders and carry a significant risk of malignant transformation, particularly erythroplakia, which has a transformation rate exceeding 30%.

• Localised Lump or Thickening: Feeling a distinct mass, nodule, or area of "fullness" inside the cheek, detectable by pressing the tongue against the inner cheek or by palpating with a finger.

• Progressive Difficulty Opening the Mouth: Gradual reduction in mouth opening (trismus), which may initially present as mild stiffness and worsen over weeks or months. This is especially significant in patients with a history of OSMF.

Advanced Symptoms

• Trismus (Severe Restriction): As the tumour invades the buccinator muscle and deeper masticatory muscles (masseter, medial pterygoid), jaw opening becomes severely limited, sometimes to less than two finger-widths.

• Pain and Referred Ear Pain (Otalgia): Deep, persistent pain in the cheek that radiates to the ear on the same side. This occurs when the tumour infiltrates sensory branches of the trigeminal nerve.

• Loosening of Teeth or Jaw Pain: If the tumour invades the adjacent jawbone (mandible or maxilla), it can erode bone, causing teeth in the area to become mobile or causing a deep, dull ache.

• Neck Lumps: A firm, painless lump in the neck indicates that cancer cells have metastasised to the cervical lymph nodes, signifying at least Stage III disease.

If you have any of these symptoms, book an appointment with Dr. Pradeep S. and Dr. Kalpa Pandya at Apollo Main Hospital, Greams Road, Chennai.

---

Causes and Risk Factors for Buccal Mucosa Cancer

The primary driver of buccal mucosa cancer is chronic chemical and physical irritation of the inner cheek lining. The most significant risk factors include:

1. Smokeless Tobacco and Areca Nut (Gutka, Paan Masala, Betel Quid): The single most important risk factor in India. Placing these products in the cheek pocket for extended periods delivers a sustained dose of carcinogenic tobacco-specific nitrosamines (TSNAs) and areca nut alkaloids directly to the buccal mucosa. Our detailed guide covers the gutka and paan masala cancer risk in full.

2. Smoking and Alcohol: Cigarette, bidi, or cigar smoke introduces heat and chemical carcinogens. Alcohol acts as a solvent that increases mucosal permeability, so the combination multiplies the risk.

3. Chronic Dental Trauma: A sharp, broken, or heavily decayed tooth, or a poorly fitting dental prosthesis that constantly rubs against the inner cheek, can create a chronic ulcer. Over months or years, the repeated cycle of cellular damage and repair can trigger malignant change.

4. Pre-Existing Oral Submucous Fibrosis (OSMF): Patients with OSMF already have fibrosis, collagen deposition, and reduced blood supply in the cheek tissue, which makes malignant change more likely. OSMF has a malignant transformation rate estimated at 7% to 13%.

5. Nutritional Deficiencies: Chronic deficiency of iron, vitamin B12, and folic acid can lead to atrophic changes in the oral mucosa, making it more vulnerable to carcinogenic insults.

---

Diagnosis: Biopsy and Pathology

A suspicious cheek lesion is worked up in a fixed sequence.

Clinical Examination

The surgeon performs a thorough visual and tactile examination of the cheek, including bimanual palpation (pressing the cheek between a finger inside the mouth and a hand outside) to assess the depth and extent of any mass. The neck is carefully examined for enlarged lymph nodes. This is the same assessment used in an oral cancer screening.

Incisional Biopsy: The Definitive Test

The definitive diagnostic step is an incisional biopsy. Under local anaesthesia, a small wedge of tissue is taken from the edge of the lesion (the junction between abnormal and normal-looking tissue) and sent to a pathologist for microscopic examination.

The pathology report will confirm:

• Whether the lesion is malignant (squamous cell carcinoma vs. dysplasia vs. benign).
• Histological grade: well-differentiated (Grade 1), Moderately differentiated (Grade 2), or Poorly differentiated (Grade 3). Poorly differentiated tumours are more biologically aggressive.
• Depth of Invasion (DOI): how deep the cancer cells have penetrated below the basement membrane. Under the AJCC 8th edition, DOI directly influences the T-stage and the decision to perform a neck dissection.
• Perineural Invasion (PNI): whether cancer cells have invaded the spaces surrounding nerves. PNI is a high-risk feature associated with local recurrence.
• Lymphovascular Invasion (LVI): whether cancer cells have entered small blood vessels or lymphatic channels, increasing the risk of regional or distant spread.

For a plain-language explanation of each of these terms, see our guide to the oral cancer biopsy and pathology report.

Radiographic Imaging for Staging

Once cancer is confirmed on biopsy, imaging is essential to map the full extent of disease:

• Contrast-Enhanced CT (CECT) or MRI: Shows the depth of tumour invasion into the cheek muscles, involvement of the masticator space, proximity to or invasion of the jawbone, and lymph node status in the neck.

• Orthopantomogram (OPG) or Cone Beam CT (CBCT): Specifically assesses whether the tumour has eroded the bone of the mandible or maxilla.

• PET-CT Scan: Reserved for advanced stages to rule out distant metastasis (lungs, liver, bones) and to assess overall disease burden.

---

Staging Buccal Mucosa Cancer

Accurate staging is essential to determine the appropriate treatment plan. Buccal mucosa cancer follows the AJCC 8th edition TNM staging system, which uses depth of invasion as well as size to set the T stage. For an overview of how oral cancers are staged, see our guide on oral cancer stages explained.

T Stage (Primary Tumour)

N Stage (Neck Lymph Nodes)

The N classification assesses whether cancer has spread to the cervical lymph nodes, including the number, size, laterality, and presence of extranodal extension (ENE), where cancer has broken through the lymph node capsule into surrounding tissue.

Why Depth of Invasion Matters

A small-looking cheek ulcer can be a deeply invasive cancer. A tumour that appears to be only 1.5 cm on the surface but has invaded 8 mm deep into the buccinator muscle is classified as T2, not T1. This depth significantly increases the probability of occult lymph node metastasis and directly influences the decision to perform a neck dissection.

---

Surgical Treatment for Buccal Mucosa Cancer

Surgery is the cornerstone of curative treatment. The primary goal is complete removal of the cancer with clear margins while preserving as much oral function and facial aesthetics as possible.

Because buccal mucosa tumours can grow rapidly and spread to adjacent tissues, the surgical plan must address three key areas: the primary tumour, the jawbone (if involved), and the lymph nodes in the neck.

1. Wide Local Excision (Cheek Resection)

The surgeon removes the entire visible tumour along with a 1 to 1.5 cm margin of healthy-looking tissue around it. This "clear margin" is essential to ensure that microscopic cancer cells at the boundaries do not cause a recurrence.

Depending on the tumour's depth and location, the excision may include:

• The full thickness of the buccinator muscle.
• The overlying skin of the cheek (if the tumour has grown outward through the muscle to involve the skin).
• A portion of the upper or lower gum tissue (alveolar mucosa) if the tumour extends toward the teeth.

A through-and-through cheek defect (where both the inner lining and outer skin must be removed) creates one of the most complex reconstructive challenges in oral oncology.

2. Neck Dissection

Even when pre-operative imaging shows no obvious lymph node involvement (a clinically N0 neck), buccal mucosa tumours carry a significant risk of occult (hidden) micrometastasis in the cervical lymph nodes. This risk is especially high when:

• Depth of Invasion exceeds 4 mm.
• The tumour is moderately or poorly differentiated.
• There is evidence of perineural or lymphovascular invasion on biopsy.

An elective neck dissection (typically selective, targeting Levels I, II, and III) is therefore routinely performed alongside the cheek resection. This both treats the neck and stages it: the removed lymph nodes are examined by the pathologist to determine if post-operative radiation is needed.

For patients with clinically positive neck nodes (palpable lumps or nodes seen on imaging), a more extensive modified radical neck dissection (Levels I-V) is performed. To understand when and why neck dissection is recommended even when scans appear clear, read our article on when mouth cancer needs a neck dissection. Procedure details are on our neck dissection page; early cheek lesions may be treated with wide local excision when margins allow.

3. Management of the Jaw

If the cancer is close to or invading the jawbone, a portion of the bone must be removed:

• Marginal Mandibulectomy: If the tumour is adjacent to the lower jaw but has not invaded the bone marrow, the surgeon removes a rim (margin) of bone from the surface, keeping the structural continuity of the jaw intact. The jaw remains functional and does not collapse.

• Segmental Mandibulectomy: If the cancer has invaded deep into the mandibular bone, a complete segment of the jawbone must be removed. This breaks the continuity of the jaw and requires immediate reconstructive surgery, typically with a fibula free flap, to rebuild a functional jawbone.

• Infrastructure Maxillectomy: If the tumour involves the upper jaw (maxilla), a portion of the hard palate and upper alveolar ridge may need to be removed. Reconstruction may involve an obturator prosthesis or a free-flap reconstruction.

4. Reconstructive Surgery

Removing a large portion of the inner cheek, and potentially parts of the jaw, skin, and adjacent structures, leaves a significant defect. Without immediate reconstruction, the patient would suffer from severe facial disfigurement, inability to open the mouth, and loss of the ability to speak, eat, or manage saliva.

At Mouth Cancer Surgeons, we specialise in advanced microvascular free-flap reconstruction performed simultaneously with the cancer resection:

• Anterolateral Thigh (ALT) Free Flap: Skin, fat, and fascia from the thigh, transplanted with its blood vessels to the cheek defect. Ideal for large through-and-through cheek defects because it provides excellent bulk to restore cheek contour.

• Radial Forearm Free Flap (RFFF): A thin, highly pliable flap from the inner forearm. Ideal for reconstructing the inner cheek lining where flexibility and movement are important for speech and swallowing.

• Fibula Free Flap: When a segment of the jawbone has been removed, the fibula bone from the lower leg, with its overlying skin and blood vessels, is used to rebuild a strong, functional jawbone. Learn more about this procedure in our guide on fibula free flap jaw reconstruction.

During reconstruction, both surgeons operate at the same time: Dr. Pradeep S. removes the tumour while Dr. Kalpa Pandya raises the reconstructive flap, which shortens the time under general anaesthesia.

---

What to Expect During Recovery

Recovery after buccal mucosa cancer surgery is a gradual, structured process. The timeline depends on the extent of the surgery. A simple wide excision recovers faster than a complex composite resection with free-flap reconstruction and neck dissection.

Phase 1: Acute Post-Operative Phase (Hospital Stay, Days 1 to 14)

• Airway Management: In major surgeries involving jaw reconstruction or extensive neck dissection, a temporary tracheostomy (breathing tube in the windpipe) may be placed to secure the airway while facial and neck swelling subsides. This is usually removed within 5 to 7 days.

• Nutrition: Patients cannot eat by mouth immediately after surgery to protect the healing cheek grafts. Nutrition is delivered via a nasogastric (Ryle's) tube. This is temporary and well-tolerated.

• Flap Monitoring: If a microvascular free flap was used, the surgical team checks the flap's colour, temperature, and blood flow by clinical assessment and Doppler ultrasound every hour for the first 48 to 72 hours.

• Pain Management: Scheduled intravenous pain medications ensure comfort. Patients are encouraged to communicate pain levels so medications can be adjusted.

• Drain Management: Surgical drains in the neck collect fluid and are typically removed within 3 to 5 days when output decreases to safe levels.

Phase 2: Early Healing (Weeks 2 to 6)

• Wound Healing: External skin sutures are removed at 7 to 10 days. Internal mucosal healing completes within 3 to 4 weeks.

• Transitioning to Oral Diet: Once the surgical team confirms that internal grafts have healed without leaks, the patient transitions from the feeding tube to clear liquids, then pureed foods, and gradually to a soft diet.

• Jaw Exercises: To prevent trismus from surgical scarring, patients must perform structured jaw-opening exercises daily using graduated mouth-opening devices. Skipping these exercises is the commonest reason mouth opening stays restricted.

• Speech Adaptation: If the reconstruction has altered the cheek volume or contour, patients may notice temporary changes in speech clarity. These improve steadily as the reconstructed tissue integrates.

Phase 3: Active Rehabilitation (Months 2 to 6)

• Speech and Swallowing Therapy: Working with specialised speech and swallowing therapists helps patients adapt to the reconstructed tissues, ensuring clear speech and safe swallowing.

• Adjuvant Therapy: If pathology reveals high-risk features (positive margins, multiple positive lymph nodes, extranodal extension, perineural invasion), the patient will be referred for post-operative radiation or chemoradiation. This typically begins 4 to 6 weeks after surgery.

• Nutritional Optimisation: A structured nutrition plan during oral cancer treatment supports healing, maintains body weight, and helps patients tolerate adjuvant therapy.

Phase 4: Long-Term Restoration (Month 6 Onwards)

• Dental Rehabilitation: Once the surgical site is completely stable and any adjuvant therapy is complete, patients who lost teeth or parts of the jaw can undergo dental implant placement to restore full chewing function.

• Scar Remodelling: Surgical scars continue to soften and fade for 12 to 18 months.

• Cancer Surveillance: Regular follow-up visits to monitor for recurrence: monthly for the first 3 months, then every 2 to 3 months in the first year, every 3 to 4 months in the second year, and every 6 months thereafter.

For a month-by-month view of recovery, see our oral cancer surgery recovery timeline.

---

Prognosis and Survival Rates

The prognosis for buccal mucosa cancer is highly dependent on the stage at diagnosis and the quality of the initial surgical treatment.

A patient diagnosed at Stage I has a far better outcome than one diagnosed at Stage IV. For more on what determines cure, read is mouth cancer curable.

High-Risk Pathological Features That Worsen Prognosis

Even within a given stage, certain pathology findings indicate a more aggressive cancer and a higher risk of recurrence:

• Positive or close surgical margins (cancer cells at or near the edge of the removed tissue).
• Multiple positive lymph nodes (more than one node containing cancer).
• Extranodal Extension (cancer cells breaking through the lymph node capsule).
• Perineural invasion (cancer growing along nerves).
• Lymphovascular invasion (cancer cells in blood vessels or lymphatic channels).
• Poorly differentiated histological grade.

When these features are present, adjuvant radiation or chemoradiation is recommended to reduce the risk of local recurrence and improve survival.

---

Multidisciplinary Care and Adjuvant Therapy

For many patients with buccal mucosa cancer, surgery is the first treatment but not the only one. Once the removed tumour and lymph nodes are fully analysed by the pathologist, a multidisciplinary tumour board determines whether additional therapy is needed.

• Adjuvant Radiation Therapy: High-energy X-rays targeted at the surgical site and neck to destroy any microscopic residual cancer cells. Typically delivered daily over 5 to 6 weeks.

• Concurrent Chemoradiation: Combining radiation with a chemotherapy agent (typically Cisplatin) to make the cancer cells more sensitive to radiation. This is the standard of care when pathology shows positive margins or extranodal extension.

We coordinate this through the multidisciplinary oncology team at Apollo Main Hospital, so radiation planning starts as soon as the pathology is back.

---

Buccal Mucosa Cancer Treatment at Mouth Cancer Surgeons, Chennai

Two surgeons share every case at Mouth Cancer Surgeons.

• Dr. Pradeep S. (MDS, FHNS, FIBCSOMS) is a head and neck surgical oncologist with international board certification. He performs the cancer resection and microvascular reconstruction.

• Dr. Kalpa Pandya (MDS, FHNS) has treated more than 1,000 oral cancer patients over ten years, with a focus on oral potentially malignant disorders, facial trauma, and dental implant rehabilitation.

Operating together shortens the time under anaesthesia, and the same two surgeons see you from the first consultation through surgery, recovery, and long-term follow-up. Both practise at Apollo Main Hospital, Greams Road, Chennai.

If you are evaluating cheek cancer symptoms or seeking a surgical opinion, book an appointment with Dr. Pradeep S. and Dr. Kalpa Pandya, or meet the team on our doctors.

References

1. National Comprehensive Cancer Network (NCCN). "Clinical Practice Guidelines in Oncology: Head and Neck Cancers." NCCN Guidelines, 2025. [https://www.nccn.org]

2. Johnson, D. E., et al. "Head and neck squamous cell carcinoma." Nature Reviews Disease Primers, 2020.

3. Indian Council of Medical Research (ICMR). "Consensus Document for Management of Buccal Mucosa Cancer." ICMR, 2014.

4. American Joint Committee on Cancer (AJCC). "AJCC Cancer Staging Manual, 8th Edition: Oral Cavity." Springer, 2017.

5. International Agency for Research on Cancer (IARC). "Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines." IARC Monographs, Vol. 85, 2004.